| Compounds and methods for targeted degradation of the androgen receptor |
2022-12-27 |
2023-3-14 |
|
| Compounds and methods for targeted androgen receptor degradation |
2022-12-23 |
2023-3-22 |
|
| Methods for making a bifunctional compound, ultrapure forms of the bifunctional … |
2022-12-06 |
2022-12-20 |
|
| Compounds and methods for the enhanced degradation of targeted proteins |
2022-11-14 |
2022-12-15 |
|
| Tetrahydronaphthalene Derivatives and Tetrahydroisoquinoline Derivatives as … |
2022-11-02 |
2023-2-10 |
|
| Methods of treating prostate cancer |
2022-10-31 |
2023-1-01 |
|
| Imide-based modulator of proteolysis and associated method of use |
2022-10-28 |
2022-12-27 |
|
| Indazole-based compounds and associated methods of use |
2022-10-18 |
2022-10-31 |
|
| Polycyclic compounds and methods for the targeted degradation of rapidly … |
2022-9-08 |
2022-9-29 |
|
| Modulators of estrogen receptor proteolysis and associated methods of use |
2022-8-23 |
2022-9-15 |
|
| Cereblon ligands and bifunctional compounds comprising the same |
2022-8-22 |
2022-9-15 |
|
| Methods of manufacturing a bifunctional compound |
2022-7-26 |
2023-3-02 |
|
| Modulators of proteolysis and associated methods of use |
2022-7-20 |
2022-8-11 |
|
| COMPOUNDS AND METHODS FOR TARGETED DEGRADATION OF THE ANDROGEN RECEPTOR |
2022-7-15 |
2022-9-30 |
|
| Compounds and methods for the targeted degradation of rapidly accelerated … |
2022-6-29 |
2022-8-01 |
|
| Compounds and methods for the targeted degradation of irak-4 |
2022-6-15 |
2022-12-22 |
|
| BRM targeting compounds and associated methods of use |
2022-6-10 |
2022-6-30 |
|
| Bifunctional molecules containing an e3 ubiquitin ligase binding moiety linked … |
2022-5-17 |
2022-5-31 |
|
| Tau-protein targeting protacs and associated methods of use |
2022-4-20 |
2023-3-23 |
|
| Methods of treating prostate cancer |
2022-4-19 |
2022-6-01 |
|
| Modulators of bcl6 proteolysis and associated methods of use |
2022-4-15 |
2022-12-15 |
|
| Indazole based compounds and associated methods of use |
2022-3-19 |
2023-3-30 |
|
| Methods of treatment of breast cancer with tetrahydronaphthalene derivatives as … |
2022-3-09 |
2022-4-08 |
|
| Cereblon ligands and bifunctional compounds comprising the same |
2022-1-07 |
2023-3-16 |
|
| Mdm2-based modulators of proteolysis and associated methods of use |
2022-1-06 |
2022-4-28 |
|
| Alanine-based modulators of proteolysis and associated methods of use |
2022-1-05 |
2022-5-26 |
|
| Methods of treating breast cancer with tetrahydronaphthalene derivatives as … |
2021-12-13 |
2022-10-01 |
|
| Methods of treating prostate cancer |
2021-12-10 |
2022-6-16 |
|
| Compounds and methods for the targeted degradation of androgen receptor and … |
2021-10-27 |
2022-5-12 |
|
| Compounds and methods for the targeted degradation of androgen receptor protein |
2021-10-20 |
2022-4-28 |
|
| Crystalline forms of a compound for the targeted degradation of estrogen … |
2021-9-13 |
2023-4-13 |
|
| Crystalline forms of a compound for the targeted degradation of estrogen … |
2021-9-13 |
2022-3-17 |
|
| Crystalline and amorphous forms of a compound for the targeted degradation of … |
2021-9-13 |
2022-3-17 |
|
| Rapidly accelerating fibrosarcoma protein degrading compounds and associated … |
2021-8-30 |
2022-4-16 |
|
| Compounds and methods for the targeted degradation of rapidly accelerated … |
2021-7-28 |
2023-1-05 |
|
| Protein-protein interaction inducing technology |
2021-6-24 |
2021-10-14 |
|
| Compounds and methods for the targeted degradation of enhancer of zeste homolog … |
2021-6-22 |
2022-12-01 |
|
| Compounds and methods for targeted degradation of kras |
2021-4-06 |
2023-2-15 |
|
| Selective modulators of mutant lrrk2 proteolysis and associated methods of use |
2021-3-19 |
2023-1-25 |
|
| Compounds and methods for the targeted degradation of interleukin-1 receptor- … |
2021-3-09 |
2022-10-20 |
|
| Egfr proteolysis targeting chimeric molecules and associated methods of use |
2021-3-04 |
2021-7-22 |
|
| TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE |
2021-1-27 |
2021-5-20 |
|
| Imide-Based Modulators of Proteolysis and Associated Methods of Use |
2020-12-24 |
2021-2-11 |
|
| Indole derivatives as estrogen receptor degraders |
2020-10-28 |
2021-2-11 |
|
| Cereblon ligands and bifunctional compounds comprising the same |
2020-10-11 |
2020-11-30 |
|
| BRM targeting compounds and related methods of use |
2020-10-01 |
2022-7-22 |
|
| Tau-protein targeting compounds and associated methods of use |
2020-7-17 |
2022-10-06 |
|
| Compounds and methods for the targeted degradation of bromodomain-containing … |
2020-6-25 |
2021-6-24 |
|
| Compounds and methods for the targeted degradation of androgen receptor |
2019-10-17 |
2022-8-30 |
2022-8-30 |
| Brm targeting compounds and associated methods of use |
2019-10-01 |
2020-2-06 |
|
| Modulators of alpha-synuclein proteolysis and associated methods of use |
2019-8-20 |
2020-3-19 |
|
| Bifunctional substitued pyrimidines as modulators of fak proteolyse |
2019-7-26 |
2020-1-30 |
|
| Compounds and methods for the targeted degradation of Androgen Receptor |
2018-7-27 |
2021-4-22 |
2021-4-22 |
| Modulators of proteolysis and associated methods of use |
2018-6-01 |
2018-12-13 |
|
| Compounds and methods for the targeted degradation of fetal liver kinase … |
2017-12-13 |
2019-10-30 |
|
| TETRAHYDRONAPPHTALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN … |
2017-12-01 |
2021-12-28 |
|
| Estrogen-related receptor alpha based protac compounds and associated methods … |
2015-8-11 |
2016-2-17 |
|
| Imide-based modulators of proteolysis and associated methods of use |
2015-7-06 |
2016-3-03 |
|
| Formes cristallines d'un compose pour la degradation ciblee du recepteur des … |
2021-9-13 |
2022-3-17 |
|
| Derivados de tetrahidronaftaleno e tetrahidroisoquinolina como degradadores do … |
2017-12-01 |
2021-12-28 |
|